Myeloid-Derived Suppressor Cells (MDSC) are expanded in children with severe viral lower respiratory tract infections and demonstrate differences in subsets and outcomes according to viral etiology
Saturday, April 29, 2023
9:00 AM – 9:15 AM ET
Location: Convention Center: 152 A
Publication Number: 1055.5
Anna Kuehn-Everson, Nationwide Childrens Hospital, Worthington, OH, United States; Katherine Bline, Nationwide Children's Hospital, Columbus, OH, United States; Octavio Ramilo, St. Jude Children's Research Hospital, Memphis, TN, United States; Asuncion Mejias, Nationwide Children's Hospital, Columbus, OH, United States; Amber Wolfe, Nationwide Children's Hospital, Columbus, OH, United States; Lisa M. Steele, Nationwide Children's Hospital, Columbus, OH, United States; Calla Edmonds, Nationwide Children's Hospital, Hilliard, OH, United States; Sara Mertz, Nationwide Children's Hospital, Columbus, OH, United States; Fang Ye, Nationwide Children's Hospital, Columbus, OH, United States
Presenting Author(s)
Anna Kuehn-Everson, B.S. in Microbiology (she/her/hers)
Research Associate Nationwide Childrens Hospital Worthington, Ohio, United States
Disclosure(s):
Anna Kuehn-Everson, B.S. in Microbiology: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Katherine Bline, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Octavio Ramilo, MD: Adagio (Ongoing) (Products/Services: Advisory Committee); Bill & Melinda Gates Foundation (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Janssen (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Lilly (Ongoing) (Products/Services: Advisory Committee); Merck (Ongoing) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator); NIH (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Pfizer (Ongoing) (Products/Services: Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness); Sanofi (Ongoing) (Products/Services: Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness)
Asuncion Mejias, MD, PhD, MsCS: Astra-Zeneca (Terminated, November 15, 2022) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Janssen (Terminated, December 31, 2022) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator); Merck (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Pfizer (Ongoing) (Products/Services: Advisory Committee); Sanofi-Pasteur (Ongoing) (Products/Services: Advisory Committee)
Amber Wolfe, Bachelor of Science in Nursing: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Lisa M. Steele, BSN: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Calla Edmonds, High School Diploma: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Sara Mertz, Bachelor of Science: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Fang Ye, Ph.D: I do not have any relevant financial / non-financial relationships with any proprietary interests.
